Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients - Fig 3
Abstract
<p>A) Overall Survival (OS) of all patients based on International Staging System (ISS) (n = 180). B) OS of patients in ISS-1 stratified by sFLCR (n = 56). C) OS of patients in ISS-2 stratified by sFLCR (n = 65). D) OS of patients in ISS-3 stratified by sFLCR (n = 59).</p- Image
- Figure
- Medicine
- Cell Biology
- Biotechnology
- Cancer
- 72 disease-related deaths
- MM patients
- 2M
- sCR
- HR
- CR -52 months
- prognostic value
- ROC
- Multiple Myeloma Patients Background
- risk stratification model
- ISS
- Disease Free Survival
- NR
- Serum Free Light Chains Measurements
- 5- years OS
- CI
- DFS
- Methods 180 patients
- sFLCR
- IC
- PFS
- sFLC ratio